423 related articles for article (PubMed ID: 11605649)
1. Molecular modelling and 1H-NMR: ultimate tools for the investigation of tolbutamide: beta-cyclodextrin and tolbutamide: hydroxypropyl-beta-cyclodextrin complexes.
Veiga FJ; Fernandes CM; Carvalho RA; Geraldes CF
Chem Pharm Bull (Tokyo); 2001 Oct; 49(10):1251-6. PubMed ID: 11605649
[TBL] [Abstract][Full Text] [Related]
2. Deformation behaviors of tolbutamide, hydroxypropyl-beta-cyclodextrin, and their dispersions.
Suihko E; Poso A; Korhonen O; Gynther J; Ketolainen J; Paronen P
Pharm Res; 2000 Aug; 17(8):942-8. PubMed ID: 11028939
[TBL] [Abstract][Full Text] [Related]
3. Multimodal molecular encapsulation of nicardipine hydrochloride by beta-cyclodextrin, hydroxypropyl-beta-cyclodextrin and triacetyl-beta-cyclodextrin in solution. Structural studies by 1H NMR and ROESY experiments.
Fernandes CM; Carvalho RA; Pereira da Costa S; Veiga FJ
Eur J Pharm Sci; 2003 Apr; 18(5):285-96. PubMed ID: 12694880
[TBL] [Abstract][Full Text] [Related]
4. Complexation with tolbutamide modifies the physicochemical and tableting properties of hydroxypropyl-beta-cyclodextrin.
Suihko E; Korhonen O; Järvinen T; Ketolainen J; Jarho P; Laine E; Paronen P
Int J Pharm; 2001 Mar; 215(1-2):137-45. PubMed ID: 11250099
[TBL] [Abstract][Full Text] [Related]
5. Solid-state 13C nuclear magnetic resonance spectroscopic study on amorphous solid complexes of tolbutamide with 2-hydroxypropyl-alpha- and -beta-cyclodextrins.
Kimura K; Hirayama F; Arima H; Uekama K
Pharm Res; 1999 Nov; 16(11):1729-34. PubMed ID: 10571279
[TBL] [Abstract][Full Text] [Related]
6. Oral bioavailability and hypoglycaemic activity of tolbutamide/cyclodextrin inclusion complexes.
Veiga F; Fernandes C; Teixeira F
Int J Pharm; 2000 Jul; 202(1-2):165-71. PubMed ID: 10915940
[TBL] [Abstract][Full Text] [Related]
7. Characterization of the complexes of furosemide with 2-hydroxypropyl-beta-cyclodextrin and sulfobutyl ether-7-beta-cyclodextrin.
Spamer E; Müller DG; Wessels PL; Venter JP
Eur J Pharm Sci; 2002 Sep; 16(4-5):247-53. PubMed ID: 12208454
[TBL] [Abstract][Full Text] [Related]
8. Study of tolbutamide-hydroxypropyl-gamma-cyclodextrin interaction in solution and solid state.
Veiga MD; Ahsan F
Chem Pharm Bull (Tokyo); 2000 Jun; 48(6):793-7. PubMed ID: 10866138
[TBL] [Abstract][Full Text] [Related]
9. Comparison of the complexation between methylprednisolone and different cyclodextrins in solution by 1H-NMR and molecular modeling studies.
Thi TD; Nauwelaerts K; Froeyen M; Baudemprez L; Van Speybroeck M; Augustijns P; Annaert P; Martens J; Van Humbeeck J; Van den Mooter G
J Pharm Sci; 2010 Sep; 99(9):3863-73. PubMed ID: 20665846
[TBL] [Abstract][Full Text] [Related]
10. Solubilization and stabilization of sodium dicloxacillin by cyclodextrin inclusion.
Echezarreta-López MM; Otero-Mazoy I; Ramírez HL; Villalonga R; Torres-Labandeira JJ
Curr Drug Discov Technol; 2008 Jun; 5(2):140-5. PubMed ID: 18673252
[TBL] [Abstract][Full Text] [Related]
11. Study on the inclusion complexes of cryptotanshinone with beta-cyclodextrin and hydroxypropyl-beta-cyclodextrin.
Li JF; Wei YX; Ding LH; Dong C
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Oct; 59(12):2759-66. PubMed ID: 14499836
[TBL] [Abstract][Full Text] [Related]
12. Nuclear magnetic resonance investigations of the inclusion complexation of gliclazide with beta-cyclodextrin.
Moyano JR; Arias-Blanco MJ; Gines JM; Rabasco AM; Pérez-Martínez JI; Mor M; Giordano F
J Pharm Sci; 1997 Jan; 86(1):72-5. PubMed ID: 9002462
[TBL] [Abstract][Full Text] [Related]
13. Influence of the preparation method on the physicochemical properties of tolbutamide/cyclodextrin binary systems.
Veiga F; Fernandes C; Maincent P
Drug Dev Ind Pharm; 2001 Jul; 27(6):523-32. PubMed ID: 11548859
[TBL] [Abstract][Full Text] [Related]
14. Inclusion complexation of propofol with 2-hydroxypropyl-beta-cyclodextrin. Physicochemical, nuclear magnetic resonance spectroscopic studies, and anesthetic properties in rat. trapani@ippo.uniba.it.
Trapani G; Latrofa A; Franco M; Lopedota A; Sanna E; Liso G
J Pharm Sci; 1998 Apr; 87(4):514-8. PubMed ID: 9548907
[TBL] [Abstract][Full Text] [Related]
15. Effects of aging on crystallization, dissolution and absorption characteristics of amorphous tolbutamide-2-hydroxypropyl-beta-cyclodextrin complex.
Kimura K; Hirayama F; Arima H; Uekama K
Chem Pharm Bull (Tokyo); 2000 May; 48(5):646-50. PubMed ID: 10823700
[TBL] [Abstract][Full Text] [Related]
16. Preparation and characterization of hydroxypropyl-β-cyclodextrin inclusion complex of eugenol: differential pulse voltammetry and (1)H-NMR.
Garg A; Gupta B; Prakash R; Singh S
Chem Pharm Bull (Tokyo); 2010 Oct; 58(10):1313-9. PubMed ID: 20930396
[TBL] [Abstract][Full Text] [Related]
17. Preparation and study on the novel solid inclusion complex of ciprofloxacin with HP-beta-cyclodextrin.
Chao J; Meng D; Li J; Xu H; Huang S
Spectrochim Acta A Mol Biomol Spectrosc; 2004 Feb; 60(3):729-34. PubMed ID: 14747100
[TBL] [Abstract][Full Text] [Related]
18. Complexation of zolpidem with 2-hydroxypropyl-beta-, methyl-beta-, and 2-hydroxypropyl-gamma-cyclodextrin: effect on aqueous solubility, dissolution rate, and ataxic activity in rat.
Trapani G; Latrofa A; Franco M; Pantaleo MR; Sanna E; Massa F; Tuveri F; Liso G
J Pharm Sci; 2000 Nov; 89(11):1443-51. PubMed ID: 11015689
[TBL] [Abstract][Full Text] [Related]
19. Multimodal inclusion complexes between barbiturates and 2-hydroxypropyl-beta-cyclodextrin in aqueous solution: isothermal titration microcalorimetry, (13)C NMR spectrometry, and molecular dynamics simulation.
Aki H; Niiya T; Iwase Y; Yamamoto M
J Pharm Sci; 2001 Aug; 90(8):1186-97. PubMed ID: 11536223
[TBL] [Abstract][Full Text] [Related]
20. Study on inclusion interaction of piroxicam with beta-cyclodextrin derivatives.
Xiliang G; Yu Y; Guoyan Z; Guomei Z; Jianbin C; Shaomin S
Spectrochim Acta A Mol Biomol Spectrosc; 2003 Dec; 59(14):3379-86. PubMed ID: 14607235
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]